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Aim of this study was to evaluate the eﬀects of short-term (7 days) N-acetylcysteine (NAC) at 1,200mg daily supplementation
on muscle fatigue, maximal oxygen uptake (VO2max), total antioxidant capacity (TAC), lactate, creatine kinase (CK), and tumor
necrotic factor-alpha (TNF-α). Twenty-nine sedentary men (13 controls; 16 in the supplement group) from a randomized control
were included. At before and after supplementation, fatigue index (FI) was evaluated in the quadriceps muscle, and performed a
graded exercise treadmill test to induce oxidative stress, and as a measure of VO2max. Blood samples were taken before exercise and
20 minutes after it at before and after supplementation, to determine TAC, CK, lactate, and TNF-α levels. Results showed that FI
and VO2max increased signiﬁcantly in the supplement group. After exercise decreased the levels of TAC and increased lactate, CK,
andTNF-αofbothgroupsatbeforesupplementation. Aftersupplementation, lactate, CK,andTNF-αlevels signiﬁcantlyincreased
and TAC decreased after exercise in the control group. Whereas the TAC and lactate levels did not change signiﬁcantly, but CK
and TNF-α increased signiﬁcantly in the supplement group. Therefore, this results showed that NAC improved the muscle fatigue,
VO2max, maintained TAC, controlled lactate production, but had no inﬂuence on CK and TNF-α.
1.Introduction
Exercise is promoted for improving general health and pre-
venting many diseases such as cardiovascular disease, dia-
betes mellitus, and cancer [1]. However, several studies have
shown that short heavy exercise may induce adverse eﬀects
associatedwithoxidativestressinuntrainedhumansthrough
various pathways such as electron leakage within mitochon-
dria, auto-oxidation of the catecholamine, NADPH activity,
or an ischemic-reperfusion [2]. Oxidative stress induces
oxidation processes in proteins, lipids, or DNA. Oxidation of
all biological molecules is a result of organ dysfunction
[3]. During muscle contraction with a short heavy load,
numerousfreeradicalsareproducedthatinducemicroinjury
or an inﬂammation process and tumor necrotic factor-alpha
(TNF-α), interleukin-6 (IL-6) [4], lactate dehydrogenase
(LDH), and creatine phosphokinase (CPK) [5] are released.
Thus, over-oxidative stress directly aﬀects physical perfor-
mance through the ability of muscles to contract to whole-
body aerobic capacity [6].
Considerable interest has been shown in ﬁnding ways
to prevent heavy exercise-induced free-radical production
and muscle injury. Nutritional supplements, such as vitamin
C (ascorbic acid) or vitamin E (alpha-tocopherol), have2 Oxidative Medicine and Cellular Longevity
been very popular among athletes and individuals [7]. Pure
glutathione(GSH),composedofglutamicacid,cysteine,and
glycine, has been proposed to prevent oxidative stress, but its
absorption and eﬀectiveness in blood is low [8]. NAC is used
clinically for patients with chronic obstructive pulmonary
disease (COPD) or acute respiratory distress syndrome
(ARDS). NAC supplementation over a short period (5 days)
signiﬁcantly decreased phagocytosis and improved the level
of GSH in the blood of COPD patients [8, 9]. Furthermore,
supplementation of NAC at low concentrations (600mg) per
day for 14 weeks reduced superoxide radicals and improved
glutathione peroxidase in healthy volunteers, while a high
dose at 1,200mg per day signiﬁcantly reduced hydrogen
peroxide (H2O2) in COPD patients [9]. Interesting evidence
showed that NAC inhibited muscle fatigue [10]. A previous
study found that NAC delayed fatigue from repeated isomet-
ric handgrip maneuvers and inhibited glutathione oxidation
in sedentary men after 150mg/Kg of NAC had been ingested
[11]. However, no studies had looked at the eﬀect of NAC
on muscle injury via CK and TNF-α using a graded exercise
test. Thus, the aim of this study was to investigate the short-
term eﬀects of NAC supplementation on muscle fatigue and
VO2max for seven days at 1,200mg per day and examine its
ability to control CK, TNF-α, and lactate in sedentary men.
2.MaterialsandMethods
All programs were approved by the Human Ethics Commit-
tee (Declaration of Helsinki) at the Faculty of Associated
Medical Sciences, Chiang Mai University, Thailand. All 36
volunteers were 20–24-year-old, nonsmoking, nonathletic,
healthy males. Their body mass index (BMI) was all within
normal range (18.5–24.9kg/m2) according to the WHO and
International Obesity Task Force.
All volunteers were randomly allocated to control
(n = 18) or NAC supplement (n = 18) groups. The sup-
plement group took 600mg of oral NAC (FLUIMUCIL
A 600, ZAMBON Switzerland, Ltd.) twice per day after
meals for 7 days, a total daily dose of 1,200mg. Over the
7 days, the researchers telephoned the volunteers daily to
ensure that they kept to regular diets and check if they had
experienced side eﬀectsfrom the NAC supplementation such
as headaches or abdominal pain. All experimental values
f o rb o t hg r o u p sw e r et e s t e da tt w ot i m e s :d a y0b e f o r e
supplementation began and day 8 after completing the 7-day
course of supplementation.
All volunteers in both the control and NAC supplement
groups participated in graded exercise on a mechanical
treadmill on day 0 and day 8. The target heart rate (THR)
was 85% of the maximal heart rate (MHR) (220-age
(yr)) per individual (American College of Sport Medicine,
ACSM; 2004) [12] and tested by following a graded exercise
program. Blood samples were taken from all volunteers
before exercise and after exercise following 20 minutes of
quiet rest. Each 10mL blood sample was taken from the
a n t e r i o rc u b i t a lv e i no fe a c hv o l u n t e e ra n dk e p ti na nE D T A
tube. Whole blood was separated to plasma for evaluation of
CBC, TAC, lactate, and TNF-α. Serum CK was analyzed at
the Central Laboratory at the Faculty of Medicine, Chiang
Mai University, Thailand.
Isometric knee-extensor of quadriceps muscle was eval-
uated using a handheld dynamometer (Chatillon DMG-250,
USA). Volunteers were positioned in a test chair, with a hip
angleof90degrees,andthekneeanglewasﬁxedat30degrees
vertically. The trunk, hip, and thigh were strapped down
to avoid involuntary movements. The individual landmark
for placing a hand-held dynamometer at the antero-inferior
region of the leg was calculated from the distance between
the tibial tuberosity and the superior aspect of the lateral
malleolus, multiplied by 0.6 [13]. Sixty repetitive static knee
extensions were performed, while maintaining the maximal
force for three seconds each. The quadriceps fatigue index
was calculated from the ﬁnal 10 repetitions, divided by the
initial 10, and multiplied by 100 [14].
A l lv o l u n t e e r sw a r m e du pb ys t r e t c h i n gl a r g em u s c l e
groups of the upper and lower extremities for three minutes.
Heart rate was recorded using a Polar heart rate monitor
(F11, USA). A graded exercise test was performed on a
mechanical treadmill, with the eight steps of a modiﬁed
Bruce protocol (three minutes for each step as follows: step
I: speed 1.7mph with 0% slope, step II: speed 1.7mph
with 5% slope, step III: speed 1.7mph with 10% slope, step
IV: speed 2.5mph with 12% slope, step V: speed 3.4mph
with 14% slope, step VI: speed 4.2mph with 16% slope,
step VII: speed 5.0mph with 18% slope, and step VIII:
speed 5.5mph with 20% slope) [15]. A rate of perceived
exertion (RPE) of 15 (hard) on a 20-point scale was the limit
set for stopping exercise as well as showing physical signs
such as muscle pain, cramp, headaches, heart palpitations,
heartburn, blurred vision, or severe dyspnea (American
College of Sport Medicine’s Guidline, 2004) [12]. Predicted
VO2max was calculated for each volunteer, using the ﬁnal
speed and grade of the treadmill [16].
Total antioxidant capacity (TAC) of fresh plasma was
assayed with ABTs cation radical decolorization [17].
Stock ABTs cation radical was produced by mixing ABTs
(14mmoL/L) and potassium persulfate (14mmoL/L)
together, and leaving in the dark overnight. Working
ABTs cation radical was diluted in deionized water until
absorbance was shown between 0.68 and 0.74 at 734nm,
before adding plasma. 10μL of plasma were added to
990μL of working ABTs cation radical and gently alternated
inversely by shaking nine times before adding in the
spectrophotometer. Decreased absorbance was recorded
continuously every minute for three minutes and ﬁnally
calculated to ΔA/min. The TAC of the plasma was calculated
by comparing with the ΔA/min of standard N-acetylcysteine
(Sigma) (0–10mmoL/L).
Lactate was detected following the original protocol of
Khantipongse [18] with a high-performance liquid chro-
matography (HPLC) system. The lactate was detected by
UV wavelengths at 240nm and separated in a C-18 HPLC
column (Phenomenex, USA) (250 × 4mm, 5μm), with a
mobile phase comprising a mixture of 0.05mol/L NaH2PO4
and acetonitrite 1% (99:1%, v/v) (pH 2.4) at a 1mL/min
ﬂow rate. The lactate concentration was compared with
standard lactate (Sigma) at 0–20mmoL/L.Oxidative Medicine and Cellular Longevity 3
The concentration of TNF-α in plasma was deter-
mined by following the guideline manual (Quantikine,
R&D Systems, Inc, Minneapolis, MN, USA). Two hundred
microliters of plasma and 50mL of external standard TNF-
α (50pg/mL) were loaded in the anti-TNF-α polyclonal
antibody-immobilized solid phase and incubated for two
hours at room temperature. After being washed three times
with wash buﬀer at 400μL, 200μL of HRP-conjugated TNF-
α was added in each well, then, incubated for two hours at
room temperature. All solutions in each well were aspirated
and washed with wash buﬀer three times before adding
400μL of substrate TMB and incubating for 20minutes
at room temperature. Finally, 50μL of stop solution (2N
sulfuric acid) was added, the blue color changed to yellow,
and the absorbance was detected at 450nm within 30
minutes by a microplate reader. Concentration of plasma
TNF-α was calculated by comparing the plasma absorbance
to the standard IL-2’s absorbances (15.6–1,000pg/mL).
All parameters (before and after exercise, at day 0
and day 8, resp.) were analyzed statistically with repeated
measurements in the General Linear Model (2 × 2f a c t o r s )
using a Least Signiﬁcant Diﬀerence (LSD) test. Values were
mean ±SE. Signiﬁcance was set at P<.05.
3. Results
There was no diﬀerence in BMI or screening CBC char-
acteristics of all volunteers at day 0 in the control and
NAC supplement groups (Table 1). Results from the CBC,
including WBC, RBC, Hb, Hct, and Plt in both groups,
showed a healthy, normal status. Of the original 36 volun-
teers, 29 completed the study (13 controls and 16 in the NAC
supplementgroup).Predictedmaximalheartrate(PreMHR)
was not diﬀerent between the control (199.38±1.78bpm)
and supplement (199.31±0.19bpm) groups and calculated
target heart rate (THR) in the two groups was nearly
identical (169.47±1.52 and 169.40±0.16bpm). At day 0
and day 8, resting HR in the control group (86.85±3.11
and 94.00±2.74bpm, P=.017) was signiﬁcantly diﬀer-
ent, but not in the supplement group (85.68±2.80 via
88.31±2.47bpm, P=.311). With exercise, the THR in
the control group at day 0 was 169.54±2.36bpm, and
172.31±1.21bpm at day 8, whereas that in the sup-
plement group at day 0 was 169.12±2.13bpm, and
172.94±1.09bpm at day 8, which showed no signiﬁcant
diﬀerence between or within groups. However, the RPE in
the supplement group was signiﬁcantly lower (14.37±0.31
at day 0 and 13.06±0.34 at day 8) when compared to the
control group (13.46±0.34 at day 0 and 13.77±0.37 at day
8). Nevertheless, comparison of RPE between both groups at
day 8 showed no signiﬁcant diﬀerence.
The percentage fatigue index (% FI) (Table 2) of the
dominant quadriceps muscle in the control and supplement
groups showed no signiﬁcant diﬀerence (80.50±3.11 and
81.42±2.90%, P=.834) at day 0 (note that the higher the
% FI, the less the fatigue). After supplementation for 7
days, the % FI for the supplement group increased more
than (from 81.42±2.99 to 90.67±2.07 %, P=.009) that in
the controls (80.51±3.11 to 86.07±2.25%, P=.140). There
Table 1: Characteristics and complete blood count data at day 0 for
volunteers in both the control and supplement group.
Control (n = 13) NAC (n = 16)
Aged (yr) 19.49±3.58 20.01±0.79
(18–22) (18–23)
BMI (kg/m2) 21.14±2.71 21.34±3.14
(17.5–28.4) (18.3–30.5)
WBC (103/μL) 6.83±1.19 6.04±1.15
(4.2–9.0) (4.8–7.9)
RBC(103/μL) 5.68±0.60 5.49±0.39
(4.9–6.6) (4.97–6.19)
Hb(gm/dL) 14.65±1.37 15.45±0.7
(11.7–16.8) (14.1–16.4)
Hct (%) 45.31±3.5 47.48±2.13
(37.1–50.9) (43.7–50.9)
Plt (103/μL) 318.84±64.7 246.5±49.68
(185–428) (155–354)
Values are mean ±SD and (Min-Max). The values represent the range.
was no signiﬁcant diﬀerence in VO2max between the two
groups at day 0 (36.03±1.75 and 38.32±1.58mL/kg/min
in the control and supplement group, resp.). Nonetheless,
after supplementation for 7 days, the supplement groups
showed a signiﬁcant increase in VO2max (38.32±1.58 to
41.14±1.35mL/kg/min, P=.009) when compared to the
control group (36.03±1.75 to 34.58±1.49 mL/kg/min,
P=.201).
For the blood markers (Table 3), the baseline TAC
at day 0 was 1.69±0.07 mmoL NAC/L and 1.58±0.06
mmoL NAC/L (P=.269) in the control and supplement
groups, respectively. At day 8, prior to exercise, the baseline
TAC was 1.73±0.02mmoL NAC/L in the control group
(with no signiﬁcant diﬀerence from day 0 (P=.584))
and 1.71±0.02mmoL NAC/L in the supplement group
(P=.296), which was not diﬀerent from the control group
levels. However, results of TAC decreased signiﬁcantly after
the exercise test in the control group at day 0 (1.69±0.07 to
1.49±0.06mmoLNAC/L,P=.000)andday8(1.73±0.02to
1.63±0.03mmoL NAC/L, P=.006), and in the supplement
group at day 0 only (1.58±0.06 to 1.38±0.05mmoL
NAC/L, P=.005). Conversely, after NAC supplementation
for 7 days, the TAC level did not reduce after exercise
(1.71±0.02 to 1.72±0.03mmoL NAC /L, P=.655), despite
there is no diﬀerence in value at baseline compared to the
control.
Levels of CK increased after exercise in the control group
at day 0 (148.8 ± 14.0 to 164.7±16.1 U/L, P=.032) and day
8 (147.7±17.8 to 163.9± 20.1 U/L, P=.015), and in the
supplement group at day 0 (176.4±16.7 to 190.5±14.3U/L,
P=.035) and day 8 (137.7±16.0 to 155.4±18.1 U/L,
P=.003). When comparing between groups at day 0 (before,
P=.157, after exercise, P=.244) or day 8 (before, P=.681,
after exercise, P=.756), there were no signiﬁcant diﬀerences.
At baseline at day 0 and 8, the levels of lactate in
the control group (1.96 ±0.35 and 2.01±0.47mmoL/L)
were no diﬀerent from those in the supplement group4 Oxidative Medicine and Cellular Longevity
Table 2: Fatigue index (%) and VO2max(mL/kg/mL) at pre- and postexercise test between the control and supplement groups.
Control (n = 13) NAC (n = 16)
Pre-ex Post-ex Pre-ex Post-ex
Fatigue index 80.50±3.11 86.07±2.19 81.42±2.99 90.67±2.07∗
(62.21–99.38) (71.84–96.35) (53.80–97.22) (75.94–99.65)
VO2max
36.03±1.75 34.58±1.49 38.32±1.58 41.14±1.35∗
(24.14–52.01) (24.13–42.22) (33.21–52.01) (33.02–52.01)
Values are mean ±SE (Min-Max). The values represent the range. ∗P<0.05 compared to pre-ex period within the group.
Table 3: Total antioxidant capacity (TAC), lactate (mmoL/L), creatine kinase (U/L), and tumor necrotic factor-alpha (TNF-α)( p g / m L )
between the control and supplement groups at day 0 and 8.
Control (n = 13) NAC (n = 16)
day 0 day 8 day 0 day 8
Pre-ex Post-ex Pre-ex Post-ex Pre-ex Post-ex Pre-ex Post-ex
TAC 1.69±0.07 1.49±0.06# 1.73±0.02 1.63±0.03# 1.58±0.06 1.38±0.05# 1.71±0.02 1.72±0.03
(1.26–1.89) (1.10–1.41) (1.65–1.80) (1.51–1.77) (0.83–1.88) (0.74–1.81) (1.66–1.86) (1.53–1.94)
Lactate 1.96±0.35 3.67±0.73# 2.01±0.47 3.84±0.61# 1.91±0.32 3.72±0.56# 2.05±0.56 2.75±0.55
(0.56–4.78) (0.34–7.45) (0.11–6.12) (0.53–6.67) (0.11–1.21) (0.11–11.30) (0.45–6.12) (0.23–6.34)
CK 148.8±14.0 164.7±16.1# 147.7±17.8 163.9±20.1# 176.4±12.7 190.5±14.3# 137.7±60.0 155.4±18.1#
(89–282) (90–290) (87–310) (95–372) (123–285) (111–301) (56–248) (95–290)
TNF-α 1.76±0.22 5.71±0.56# 1.40±0.15 5.68±0.52# 1.86±0.19 6.93±0.51# 1.38±0.13 5.06±0.47#
(0.78–3.12) (4.81–8.45)# (0.78–2.34) (2.56–7.65) (0.87–3.56) (3.42–9.89) (0.67–2.12) (2.12–9.48)
Values are mean ± S.E (Min-Max). The values represent the range. #P<0.05 compared to pre-exercise (pre-ex) period on the same day.
(1.91±0.32, P=.919 and 2.05±0.56, P= 0.982). Exercise
increased lactate at day 0 in the control group (1.96±0.35 to
3.67±0.73, P=.049) and the supplement group (1.91±0.32
to 3.72±0.56, P=.029), as well as at day 8 in the control
group (2.01±0.47 to 3.84±0.61, P=.034). However, after
7 days of supplementation, the lactate level did not increase
signiﬁcantly (2.05±0.56 to 2.75±0.55, P=.353) in the
supplement group when compared to the control group.
TNF-α levels at baseline (day 0) in the control (1.76±
0.22pg/mL) and supplement group (1.86±0.19pg/mL)
(P=.157) were similar. In addition, no signiﬁcant diﬀerence
was noted between the control and supplement groups at
baseline at day 8 (1.40±0.15pg/mL and 1.38±0.13pg/mL,
P=.915). After exercise, TNF-α signiﬁcantly increased in
the control group (day 0: 1.76±0.22 to 5.71±0.56pg/mL,
P=.000; day 8: 1.40±0.15 to 5.68±0.52pg/mL, P=
.000) and supplement group (day 0; 1.86±0.19 to
6.93±0.51pg/mL, P=.000 and day 8; 1.38±0.13 to
5.06±0.47pg/mL, P=.000). No diﬀerences between groups
were noted in this response (P=.385).
4. Discussion
This study used NAC to replace pure GSH because pre-
vious evidence showed that oral supplement of pure GSH
at 3.0mg had low absorption and no signiﬁcance when
maintained in plasma and compared to the control group
[19].Orally-administeredNACat600mginhumansresulted
in a mean maximum plasma concentration of L-cysteine
of 4.6μmol/L and a mean cysteine concentration from
10μm o / Lt oam a x i m u ml e v e lo f1 8 . 6 μmol/L after one
hour [20]. In the pharmacokinetics of NAC after oral
administration in a rat model, 77% was maintained in the
bodywith3%extractedinfeces,andthemajormetabolitesas
cysteine and cystine in the liver and inorganic sulphate were
urinary excretion products [21]. However, a previous study
showed that a high concentration of NAC (1.8g daily for 2
weeks) increased plasma cysteine but did not improve the
plasma GSH signiﬁcantly [22]. Therefore, it is possible that
despite increases in cysteine, the antioxidant eﬀects of GSH
might not be realized.
In a previous evaluation [23], high reliability of fatigue
measurements could be calculated from 50 maximal concen-
tric contractions performed on a dynamometer. However,
the fatigue index in this study was modiﬁed by using 60
repetitive contractions, as all volunteers were healthy young
men. The data showed that the resting percentages of fatigue
index in the control group at day 0 and day 8 were not
signiﬁcantly diﬀerent; however values for the supplement
g r o u pi m p r o v e df r o md a y0t od a y8( T a b l e2).
Previous evidence has shown that lactate does not
aﬀect muscle fatigue, but inorganic phosphate from creatine
phosphate was the main cause of it [24]. Furthermore,
muscle fatigue may be related to increases in free radicals
in skeletal muscle ﬁbers. Early work has demonstrated that
the free radicals scavenger, NAC, delays muscle fatigue [25].Oxidative Medicine and Cellular Longevity 5
In this study, a signiﬁcant change of 81.42±2.99% at day
0 to 90.67±2.07% at day 8 was noted in the fatigue index
within the supplement group at day 8 after 7 days of NAC
supplementation.
In addition to the fatigue index, estimated VO2max
increased with NAC treatment. At day 0, the VO2maxlevel of
the supplement group showed no diﬀerence from that in the
control group. After 7 days of supplementation, the VO2max
level increased (at day 8) in the supplement group, when
compared to the control group. Taken collectively, it appears
that NAC may provide an ergogenic beneﬁt, but the results
were mixed.
This study did not evaluate the NAC in plasma, but a
previous report showed that the level of cysteine in NAC
increased after orally supplementing NAC at 400mg per
single dose to 4mg/L in plasma [26]. The results showed
that the TAC in the supplement group increased after
supplementation at day 8, when compared to day 0, but
with no signiﬁcant change. The results showed the beneﬁt
of NAC in maintaining the TAC levels, which were found to
be eﬀective in protecting against oxidative stress after graded
exercise, when compared with the control group.
Exercise that induces systemic inﬂammation by releasing
many cytokines such as interleukin-6 (IL-6), interleukin-1
(IL-1), interleukin-10 (IL-10), TNF-α, and CK is related to
muscle damage [27, 28]. This study showed a signiﬁcantly
high concentration of CK after exercise in both groups at
day 0 and day 8. TNF-α increased signiﬁcantly in both
groups at day 0 and day 8. No eﬀect was observed with NAC
supplementation, while in a previous study on NAC supple-
mentation, a longer period of treatment (3 months) showed
a signiﬁcant decrease in TNF-α [11]. Lactate increases in
an intensity-dependent manner with exercise, possibly from
1.5mmoL/Latrestto12.3mmoL/Lafterrunning[29].Italso
presents within blood 20 minutes after exercise and returns
to resting level within two hours [30]. This study detected
plasma lactate after 20 minutes exercise and results showed
a signiﬁcant increase in the control and supplement groups.
After NAC supplementation for 7 days, the lactate response
to exercise was less than that at day 0, suggesting the possible
beneﬁt of NAC supplementation.
Overall results indicated that NAC at 1,200mg daily can
reduce oxidative stress from short exercise. However, the
contrast in application still needs more proof because low
levels of free radicals that generate in mitochondria are very
important for normal muscle force, and they increase more
with stronger force [31]. Previous reports suggested that
antioxidants such as vitamin C and vitamin E might inhibit
the defense mechanism or adaptive response from exercise-
induced free radicals [32]. In addition, supplementation of
vitamin C for 8 weeks improved VO2max in trained men,
but there were adverse eﬀects from expression reduction of
key transcription factors such as Mn-SOD and PGx in a rat
model [33]. Finally, much evidence has recommended that
supplementation of antioxidant aﬀected cellular adaptation
by either downregulation or upregulation pathways. This
study also needed more speciﬁc evidence of NAC showing
the beneﬁts or adverse eﬀects between low- and high-dose
supplementation in the future.
5. Conclusion
This study shows that supplementation of FLUIMUCIL,
which contains mainly NAC, at 1,200mg daily for 7 days,
helps to protect from muscle fatigue and may maintain TAC
following strenuous exercise. However, it does not inﬂuence
CK and TNF-α release.
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